Sr. Director of Business Development, Biologics CRO/CDMO at Aurigene Pharmaceutical Services Limited
📍 Skillman, New Jersey, United States
Jenny Yip is a Ph. D. level scientist leading US Business Development for Biologics Discovery at Aurigene Services. A graduate of the Albert Einstein College of Medicine, she leverages her extensive research background in oncology and metabolic diseases to drive strategy in the CRO/CDMO space. Colleagues describe her as a "go-getter, " "meticulous, " and an "independent" scientist.
Her career represents a unique trajectory from a hands-on research scientist focused on molecular target validation to a senior leader in commercial development for biologics.
Read the full overview →
Experience
9 Years
Current Role
Sr. Director of Business Development, Biologics CRO/CDMO
Job Level
Senior
Location
Skillman, New Jersey, United States
Personality Overview
How Jenny shows up
Cautious & Analytical
Not Easily Convinced
Value Seeker
They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.
Priorities
Topics Jenny cares about
Biologics Discovery
Her current role as Head of US Business Development is focused on biologics discovery and manufacturing services, as shown in her recent conference attendance.
CRO/CDMO Partnerships
Her career at Aurigene, Curi, and Pharmaron demonstrates a consistent focus on building business for contract research and manufacturing organizations.
+5 more topicsLogin to view topics
Career
Work history
5-2024
Sr. Director of Business Development, Biologics CRO/CDMO
Aurigene Pharmaceutical Services Limited
1-2023 - 5-2024
Director of Business Development | Large Molecules Drug Discovery
Curia
4-2021 - 1-2023
Director of Business Development | Cell & Gene Therapy CRO & CDMO
Pharmaron
10-2020 - 3-2021
Director Of Business Development | Mid-Atlantics Region
PhenoVista Biosciences
6-2016 - 9-2020
NY/NJ Account Manager
Eurofins Discovery
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Aurigene Pharmaceutical Services Limited Employees
Explore more public profiles from related professionals.